Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2001
11/13/2001US6316195 Method for differentiating between the casual agents of karnal bunt wheat fungus and ryegrass smut using PCR
11/13/2001US6316194 Methods and kits for discovery of RNA-binding antimicrobials
11/13/2001US6316191 Sequence determination of preferential nucleotide sequences; determine hybridization values for probes and nucleotide sequences, compare and evaluate to target nucleotide sequences, determine sequence
11/13/2001US6316190 Oligonucleotides which specifically bind retroviral nucleocapsid proteins
11/13/2001US6316189 Evaluation of changes in breast cells using nipple aspirate fluid
11/13/2001US6316188 Histamine-N-methyltransferase variants associated with histaminergic disease
11/13/2001US6316186 Determining concentration of particles in sample; incubate sample with binding agent, incubate sample with solid support, determine concentration of preferential particle in sample by monitoring binding
11/13/2001US6316185 Quantitation of viruses by light scattering
11/13/2001US6316184 Diagnosing cancer in animals; obtain animal body fluid, determine the sequnce of preferential protein in sample, the presence of preferential protein indicates leukemia
11/13/2001US6316182 Detection of reverse transcriptase by DNA hybridization assay
11/13/2001US6316181 Expression plasmid for use in the evaluation of tumor cell migration and positioning
11/13/2001US6316180 Monitoring sample for preferential particles; expose sample to label, incubate and detect luminescent signal from sample
11/13/2001US6315994 Providing pancreatic tissue comprising islet cells and acinar cells; encapsulating in matrix comprising gelatin and polar amino acid selected from arginine, lysine, histidine, glutamic acid, and aspartic acid; introducing transplant into host
11/13/2001US6315958 Flow cell for synthesis of arrays of DNA probes and the like
11/13/2001US6315953 Devices for molecular biological analysis and diagnostics including waveguides
11/13/2001US6315902 Device for selectively filtering under reduced pressure and for vacuum drying sample liquids or drops of sample liquids
11/13/2001CA2303505C A monoclonal antibody against estrogen stimulated leucine aminopeptidase
11/13/2001CA2064793C Hydrolytic enzyme inhibitors and substrates and assays, methods and kits embodying same
11/12/2001CA2347505A1 Quenching oligonucleotides
11/12/2001CA2345915A1 Gpi-anchored small leucine-rich proteoglycan gene
11/08/2001WO2001084463A2 Apparatus, method, and computer program product for quantitative analysis of a nucleic acid amplification reaction
11/08/2001WO2001084197A1 Micro-array evanescent wave fluorescence detection device
11/08/2001WO2001084157A2 Compositions for detection of multiple analytes
11/08/2001WO2001084153A2 Diagnostic device with multiple independent flow paths
11/08/2001WO2001084150A1 Biochip for the archiving and medical laboratory analysis of biological sample material
11/08/2001WO2001084149A2 Diagnostics and therapeutics for macular degeneration-related disorders
11/08/2001WO2001084148A2 Pharmacogenomics and identification of drug targets by reconstruction of signal transduction pathways based on sequences of accessible regions
11/08/2001WO2001084147A1 Method and composition for analyzing a carbohydrate polymer
11/08/2001WO2001084146A2 A sensitive, multiplexed mass-spectrometry-based biosensor based on immuno-pcr
11/08/2001WO2001084145A2 Device for monitoring analytes at sub-micromolar concentrations
11/08/2001WO2001084142A1 Electrochemical sensing
11/08/2001WO2001084141A1 Assay for acetylcholinesterase inhibitors
11/08/2001WO2001084139A1 Significance analysis of microarrays
11/08/2001WO2001083829A1 Method of diagnosing hbv infection stages
11/08/2001WO2001083828A1 TGFβ-RII PROMOTER POLYMORPHISMS
11/08/2001WO2001083826A2 Methods and reagents for assembling molecules on solid supports
11/08/2001WO2001083825A2 Colloid compositions for solid phase biomolecular analytical systems
11/08/2001WO2001083824A2 Polynucleotide probes for detection and quantitation of candida albicans and candida dubliniensis
11/08/2001WO2001083823A1 Methods and compositions for polynucleotide analysis using generic capture sequences
11/08/2001WO2001083822A2 Use of representations of dna for genetic analysis
11/08/2001WO2001083821A2 Polynucleotide probes for detection and quantitation of candida species
11/08/2001WO2001083820A1 Methods and compositions for the manufacture of molecular beacons
11/08/2001WO2001083819A2 Methods for designing exogenous regulatory molecules
11/08/2001WO2001083817A1 Method for detecting product of nucleic acid synthesizing reaction
11/08/2001WO2001083816A2 Method for detecting tumors
11/08/2001WO2001083815A1 Method for the detection of minority genomes in virus quasispecies using dna microchips
11/08/2001WO2001083814A2 Assay for nucleic acid analysis
11/08/2001WO2001083813A1 Identification of genetic markers
11/08/2001WO2001083812A2 Method and probes for the genetic diagnosis of hemochromatosis
11/08/2001WO2001083811A1 Gamma secretase substrates and in vitro assays
11/08/2001WO2001083810A2 Analytical method and apparatus for monitoring a microbial material in a fluid sample
11/08/2001WO2001083793A2 Targeted modification of chromatin structure
11/08/2001WO2001083782A2 Novel proteases
11/08/2001WO2001083775A2 Proteases
11/08/2001WO2001083772A1 Splice variant of camp phosphodiesterase type 7 (pde7a3)
11/08/2001WO2001083771A2 Human phospholipase c delta 5
11/08/2001WO2001083768A2 Serine-threonine kinase
11/08/2001WO2001083751A2 Methods for binding an exogenous molecule to cellular chromatin
11/08/2001WO2001083749A2 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
11/08/2001WO2001083746A2 Regulatory nucleic acid sequences of the abc1 gene
11/08/2001WO2001083745A1 New gtpase-activating protein 1
11/08/2001WO2001083744A2 Natrium-calcium exchanger protein
11/08/2001WO2001083738A1 Sex determinative differentiation regulatory factor
11/08/2001WO2001083733A1 Method of screening drug acting on cell wall
11/08/2001WO2001083732A2 Databases of regulatory sequences; methods of making and using same
11/08/2001WO2001083705A1 Myocardial cell proliferation-associated genes
11/08/2001WO2001083701A2 Light-driven energy generation using proteorhodopsin
11/08/2001WO2001083696A2 Methods for rapid isolation and sequence determination of gene-specific sequences
11/08/2001WO2001083691A2 System for identifying and analyzing expression of are-containing genes
11/08/2001WO2001083674A1 Biological identification system with integrated sensor chip
11/08/2001WO2001083672A1 Reflective disc assay devices, systems and methods
11/08/2001WO2001083621A2 Sulfonated [8,9]benzophenoxazine dyes and the use of their labelled conjugates
11/08/2001WO2001083563A2 Method of identifying agents that alter the activity of the promoter sequence for crf receptor 2-alpha
11/08/2001WO2001083555A2 Pain signaling molecules
11/08/2001WO2001083554A2 Anti-inflammatory compounds and uses thereof
11/08/2001WO2001083547A2 Anti-inflammatory compounds and uses thereof
11/08/2001WO2001083543A1 Human wingless-like gene
11/08/2001WO2001083524A2 Rna metabolism proteins
11/08/2001WO2001083514A2 Nucleic acids encoding a regulator of a g protein signaling, rgs18, and uses thereof
11/08/2001WO2001083510A1 29 human secreted proteins
11/08/2001WO2001083505A1 In vivo assay for identifying nucleic acid sequences involved in alveolar loss, development and nucleic acid sequences identified thereby
11/08/2001WO2001083504A1 Colon carcinoma related polynucleotides
11/08/2001WO2001083502A1 Tag library compounds, compositions, kits and methods of use
11/08/2001WO2001083499A2 Haplotypes of the il8 gene
11/08/2001WO2001082975A2 Membrane-permeant peptide complexes for medical imaging
11/08/2001WO2001082963A2 Method of identifying and producing antigen peptides and use thereof as vaccines
11/08/2001WO2001082948A2 Uses of tgap7 for the modulation of leucocyte activation
11/08/2001WO2001082870A2 A method for activating only the vascular endothelial growth factor receptor-3 and uses thereof
11/08/2001WO2001082780A2 Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents
11/08/2001WO2001082776A2 Methods and compositions for the diagnosis of schizophrenia
11/08/2001WO2001082775A2 Methods and compositions for the diagnosis of schizophrenia
11/08/2001WO2001082774A2 Methods and compositions for the diagnosis of schizophrenia
11/08/2001WO2001082703A1 In situ growth, freezing and testing of cultured cells
11/08/2001WO2001082685A1 Use of the maize x112 mutant ahas 2 gene and imidazolinone herbicides for selection of transgenic monocots, maize, rice and wheat plants resistant to the imidazolinone herbicides
11/08/2001WO2001049886A8 Method of analyzing a nucleic acid
11/08/2001WO2001046672A8 Apparatus and method for removing small molecules and ions from low volume biological samples
11/08/2001WO2001046474A8 Detection of nucleic acids
11/08/2001WO2001041801A3 Mutant simplex virus for treating unwanted hyperproliferative cell growth
11/08/2001WO2001040460A8 Screening method for compounds capable of modularing egr-1-regulated expression
11/08/2001WO2001038877A3 Multiblot kinase analysis